Warning Letter — Wellmill, LLC dba Vitamix Laboratories
The FDA issued a Warning Letter to Wellmill, LLC (doing business as Vitamix Laboratories) on April 20, 2026, following an oversight by the Human Foods Program.
This action affects Wellmill, LLC dba Vitamix Laboratories and personnel involved in their food/supplement manufacturing, quality control, and regulatory compliance operations.
The issuance of a Warning Letter under the Human Foods Program indicates that the FDA identified significant violations of regulatory requirements during its evaluation. This likely signifies a breakdown in quality systems or manufacturing standards that could lead to further enforcement actions, such as seizures or injunctions, if not remediated to the agency's satisfaction.
Conduct an immediate audit of Current Good Manufacturing Practice (cGMP) adherence within the Human Foods Program framework. Regulatory teams should review existing quality systems to ensure they align with the requirements cited in recent Human Foods Program enforcement actions.
FDA Warning Letter issued to: Wellmill, LLC dba Vitamix Laboratories. 04/20/2026 — Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wellmill-llc-dba-vitamix-laboratories-725655-04202026
Open in openFDA / FDA.gov